Showing results (2631-2640 of 2,708) with videos related to

Sort By:
Pageof 271
Journal of Medicinal Chemistry|January 24, 2003
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinonesSteven L Colletti, Jessica L Frie, Elizabeth C Dixon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 29, 2014
A common variant in RAB27A gene is associated with fractional exhaled nitric oxide levels in adultsE Bouzigon, R Nadif, E E Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2005
p38 MAP kinase inhibitors: metabolically stabilized piperidine-substituted quinolinones and naphthyridinonesJianming Bao, Julianne A Hunt, Shouwu Miao, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncologyPeter L Greenberg, Eyal Attar, John M Bennett, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2023
A functional genomics pipeline to identify high-value asthma and allergy CpGs in the human methylomeAndréanne Morin, Emma E Thompson, Britney A Helling, et al.
Nature Communications|March 26, 2022
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogensKade D Roberts, Yan Zhu, Mohammad A K Azad, et al.
Contemporary Clinical Trials|February 22, 2023
A patient-centered nurse-supported primary care-based collaborative care program to treat opioid use disorder and depression: Design and protocol for the MI-CARE randomized controlled trialLynn L DeBar, Michael A Bushey, Kurt Kroenke, et al.
Biorxiv : the Preprint Server for Biology|June 16, 2021
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cellsMatthew Mahoney, Vishnu C Damalanka, Michael A Tartell, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2021
A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cellsMatthew Mahoney, Vishnu C Damalanka, Michael A Tartell, et al.
Pageof 271